Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07256704 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypnosis and Attention in Patients With a Neurological Disease (Stroke, Traumatic Brain Injury and Multiple Sclerosis)

Study acronym: HYPNOVA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Interventions: Hypnosis (Other) to Intervention Hypnosis (Other)
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description shortened, about 59 words
    • Eligibility criteria expanded, about 2 words
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Luzerner Kantonsspital
20 trials monitored
See all monitored trials
Stroke
3,531 trials monitored
See 153 trials at risk
Multiple Sclerosis
1,011 trials monitored
See 34 trials at risk
ADHD
411 trials monitored
See 26 trials at risk
This feasibility study investigates the potential of hypnosis as a complementary therapy for improving attentional deficits and reducing fatigue in patients with neurological conditions such as stroke, traumatic brain injury (TBI), and multiple sclerosis (MS). These patients often experience reduced spontaneous visual exploration and impaired functional independence despite current rehabilitation approaches. By integrating hypnosis with standard care and using EEG to monitor brain activity during hypnosis and sham-hypnosis sessions, this trial aims to evaluate the feasibility, acceptability, and preliminary efficacy of hypnosis in enhancing attention and reducing fatigue.
Trial Details
NCT Number NCT07256704
Lead Sponsor Luzerner Kantonsspital
Conditions
(from sponsor)		 Stroke, Traumatic Brain Injury, Multiple Sclerosis
Related terms Attention Deficit Disorder with Hyperactivity, Brain Injuries, Traumatic, Multiple Sclerosis, Stroke
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov